Impact of glucose metabolism on PD-L1 expression in sorafenib-resistant hepatocellular carcinoma cel...
Impact of glucose metabolism on PD-L1 expression in sorafenib-resistant hepatocellular carcinoma cells
About this item
Full title
Author / Creator
Cho, Sua , Kim, Wonjin , Yoo, Dayoung , Han, Yeonju , Hwang, Hyemin , Kim, Seunghwan , Kim, Jimin , Park, Sanghee , Park, Yusun , Jo, HanHee , Pyun, Jae-chul and Lee, Misu
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
Hepatocellular carcinoma (HCC) is the fifth leading cause of cancer-related mortality worldwide. Programmed cell death ligand-1 (PD-L1) is an immune checkpoint protein that binds to programmed cell death-1 (PD-1), which is expressed in activated T cells and other immune cells and has been employed in cancer therapy, including HCC. Recently, PD-L1 o...
Alternative Titles
Full title
Impact of glucose metabolism on PD-L1 expression in sorafenib-resistant hepatocellular carcinoma cells
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_3ecf5e71e2564a028f2d97e183f5114d
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_3ecf5e71e2564a028f2d97e183f5114d
Other Identifiers
ISSN
2045-2322
E-ISSN
2045-2322
DOI
10.1038/s41598-024-52160-x
